The role of serotonin receptors in the action of atypical antipsychotic drugs
Authors:
- Bw MasseyBMBw Massey
- 1 February 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 11 (1) , 59-67
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Serotonergic regulation of neuronal excitability in the prefrontal cortexNeuropharmacology, 2011
- Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneJournal of Psychopharmacology, 2010
- Evaluation of the clinical efficacy of asenapine in schizophreniaExpert Opinion on Pharmacotherapy, 2010
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease PsychosisNeuropsychopharmacology, 2009
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoPsychopharmacology, 2009
- Activation of 5-HT2A/C Receptors Counteracts 5-HT1A Regulation of N-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal CortexJournal of Biological Chemistry, 2008
- Inactivation of the 5-HT7 Receptor Partially Blocks Phencyclidine-Induced Disruption of Prepulse InhibitionBiological Psychiatry, 2008
- Molecular Targets for Treating Cognitive Dysfunction in SchizophreniaSchizophrenia Bulletin, 2007
- The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in miceJournal of Neural Transmission, 1999
- Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patientsJournal of Neural Transmission, 1991